...

Logo Pasino du Havre - Casino-Hôtel - Spa
in partnership with
Logo Nextory

EU approves new twice-yearly HIV prevention jab

Business • Aug 26, 2025, 12:57 AM
3 min de lecture
1

The European Commission has formally approved a twice-yearly injection to prevent HIV, clearing the way for the jab to be rolled out across the European Union, according to drugmaker Gilead.

The decision comes one month after regulators from the European Medicines Agency (EMA) recommended the first-of-its-kind medicine, which has been hailed as a game-changer in the course of the HIV epidemic.

The drug, called lenacapavir, is a form of pre-exposure prophylaxis (PrEP), which works by preventing the virus from replicating and spreading within the body. It reduces the risk of acquiring HIV among both adults and adolescents.

In clinical studies, the jab was 100 per cent effective at preventing the virus, prompting experts to call it one of the biggest medical breakthroughs of 2024.

The drug will be sold as Yeytuo in the European Union, Norway, Iceland, and Liechtenstein. It will be the first twice-yearly PrEP option available, replacing the need for daily pills.

Dr Dietmar Berger, Gilead Sciences’ chief medical officer, said in a statement that the Commission’s quick approval underscores the “transformative potential of Yeytuo to help address the urgent unmet need in HIV prevention across Europe”.

The new treatment comes amid a rise in HIV cases. In 2023, there were more than 24,700 new HIV diagnoses in the EU, Iceland, Liechtenstein, and Norway, up 11.8 per cent from 2022.

The US Food and Drug Administration (FDA) has also approved the drug, and the World Health Organization (WHO) has recommended it as an additional option to prevent HIV.

Gilead said it is also seeking approval for lenacapavir in Australia, Brazil, Canada, South Africa, and Switzerland, and that it will soon add Argentina, Mexico, and Peru to the list.

The company has also agreed to sell generic versions of the drug in 120 lower-income countries with high HIV rates. But it is not yet clear how widely available it will be after the United States, which has traditionally been a major global health donor, slashed funding earlier this year.

HIV affects about 40.8 million people worldwide. An estimated 630,000 people died from AIDS-related illnesses last year.


Today

Will Ukraine’s new long-range Flamingo cruise missile put Russia on red alert?
Business • 2:00 PM
11 min
Ukraine unveiled the FP-5 “Flamingo,” a domestically made long-range cruise missile. Could it significantly impact Russia's war with its powerful capabilities?
Read the article
EU defends sovereign right to regulate tech against Trump's latest tariff threat
Business • 1:16 PM
5 min
The European Commission has defended its sovereign right to regulate in reaction to Donald Trump's threat of retaliation against Big Tech laws.
Read the article
Leading AI chatbots, including ChatGPT, struggle to respond to all queries about suicide, study says
Business • 11:05 AM
5 min
The researchers called for chatbots to be fine-tuned to ensure their responses are aligned with expert guidance on suicide-related topics.
Read the article
Nissan shares plummet more than 6% as Mercedes-Benz sells its stake
Business • 10:51 AM
2 min
Nissan shares fell as German carmaker Mercedes-Benz, the second-biggest shareholder in the ailing Japanese carmaker, sold its stake.
Read the article
Heatwaves may be speeding up your biological ageing, study warns
Business • 10:44 AM
5 min
A new study suggests repeated heatwave exposure could speed up biological ageing, hitting outdoor workers, rural residents, and communities with limited air conditioning the hardest.
Read the article
Biscuits recalled in parts of Spain due to possible metal contamination
Business • 8:50 AM
1 min
The recall applies to Fontaneda brand Pim's Orange Biscuits.
Read the article
Trump threatens tariffs on nations imposing digital taxes on US tech
Business • 8:46 AM
3 min
The president said the taxes against US firms “give a complete pass to China’s largest tech companies”.
Read the article
US confirms rare case of flesh-eating parasite. Here’s what to know about the New World screwworm
Business • 8:43 AM
5 min
New World screwworm is a fly that lays its eggs in open wounds and body openings.
Read the article
Elon Musk’s xAI sues Apple and OpenAI over stifling AI competition in antitrust lawsuit
Business • 8:02 AM
5 min
“In a desperate bid to protect its smartphone monopoly, Apple has joined forces with the company that most benefits from inhibiting competition and innovation in AI: OpenAI," the lawsuit reads.
Read the article
Highly potent cannabis products tied to risk of psychosis, schizophrenia, and addiction, study finds
Business • 5:00 AM
4 min
Cannabis products today tend to be much stronger than the plant itself, raising concerns among researchers and policymakers about their health effects.
Read the article
EU approves new twice-yearly HIV prevention jab
Business • 12:57 AM
3 min
The new treatment option comes amid a rise in HIV cases in parts of Europe.
Read the article
Eli Lilly’s once-daily weight loss pill succeeds in latest trial, paving the way for global approval
Business • 12:02 AM
3 min
Lilly said it plans to ask regulators to approve the drug by the end of 2025.
Read the article